CASI PHARMACEUTICALS, INC. Excess Stock, Shares Authorized
CASI PHARMACEUTICALS, INC. (CASIF) had Excess Stock, Shares Authorized of 100 shares as of 2024-12-31, per its 20-F filed 2025-03-31.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure
us-gaap:ExcessStockSharesAuthorized · last filed 2025-03-31
- 2024-12-31: Excess Stock, Shares Authorized 100.00 shares.
| Period end | Excess Stock, Shares Authorized |
|---|---|
| 2024-12-31 | 100.00 shares 20-F · filed 2025-03-31 |